Drug Profile
SDF-1 gamma
Alternative Names: CordaChron; SDF-1γ; Stromal cell-derived factor-1 gammaLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Neuraxo Biopharmaceuticals
- Class CXC chemokines
- Mechanism of Action Chemokine CXCL12 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Spinal cord injuries
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Spinal-cord-injuries in Germany (Parenteral)
- 07 Dec 2010 This programme is still in active development
- 29 Jul 2005 SDF-1γ is available for licensing for non-neuronal applications (http://www.neuraxo.com)